NMMC Issues Notices To Three Hospitals For Asking Patients’ Kin To Arrange Remdesivir

Navi Mumbai : The Navi Mumbai Municipal Corporation (NMMC) has issued show cause notices to three private hospitals for allegedly asking the relatives of COVID-19 patients to arrange Remdesivir injection. The civic body had already instructed all the hospitals treating novel coronavirus patients that the onus of arranging the anti-viral injection was on the hospital and not on the patient.

NMMC Commissioner Abhijit Bangar said that directions were issued to the hospitals that Remdisivir should be used as per the guidelines laid down by the Maharashtra State Task Force and the Indian Council of Medical Research.

“Hence, a special order was issued stipulating that no hospital should prescribe the injection either to the patient or their relatives, as it is the responsibility of the hospital to procure the required vials through the collectorate. It was also mentioned that action would be taken against the hospital in case of any violation,” Mr. Bangar said.

Asking the patient’s relatives to arrange Remdesivir added to their anxiety and tension and increased the possibility of its black marketing, considering the current shortage, he said.

The hospitals that have been issued notices are Sunshine Hospital in Sector 16, Nerul, Siddhika Nursing Home in Sector 15, Koparkhairane, and Om Gagangiri Hospital in Sector 18, Koparkhairane.

If the hospitals failed to give a satisfactory reply, an FIR would be registered against them under the Epidemic Diseases Act and the Indian Penal Code, Mr. Bangar said.

  • Related Posts

    Wegovy, Ozempic regain weight as Indian generics fall behind

    Mumbai: Novo Nordisk’s weight-loss GLP-1 drug semaglutide branded as Wegovy and Ozempic are clawing back their lost ground with steady month-on-month sales growth as the frenzy of Indian generics begins…

    Drug regulator orders fresh safety labels for five common antimicrobials

    The updated warnings are intended to alert doctors and patients to rare but potentially serious reactions that surfaced after the medicines entered widespread clinical use. New Delhi: India’s drug regulator…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Wegovy, Ozempic regain weight as Indian generics fall behind

    Wegovy, Ozempic regain weight as Indian generics fall behind

    Drug regulator orders fresh safety labels for five common antimicrobials

    Drug regulator orders fresh safety labels for five common antimicrobials

    Rajasthan recalls labour-inducing drug after quality test failure

    Rajasthan recalls labour-inducing drug after quality test failure

    ‘Made in India’ Surgical Robot SSiMantra makes Powerful Presence felt in UK

    ‘Made in India’ Surgical Robot SSiMantra makes Powerful Presence felt in UK

    Indian nutraceutical industry unites at NUTRAVISION @2047

    Indian nutraceutical industry unites at NUTRAVISION @2047

    Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route

    Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route